Literature DB >> 2789072

Effect of diclofenac on prostaglandin E and hyaluronic acid production by human synovial fibroblasts stimulated with interleukin-1.

F A Meyer1, I Yaron, V Mashiah, M Yaron.   

Abstract

Cultured human synovial fibroblasts were stimulated with human recombinant interleukin 1 beta to overproduce prostaglandin E (PGE) and hyaluronic acid (HA). Diclofenac, indomethacin and hydrocortisone inhibited stimulation of PGE production. Half-maximal inhibition occurred at 1.10 x 10(-9), 2.79 x 10(-8) and at 5.52 x 10(-8) M, respectively. Diclofenac or indomethacin had no effect on HA production, while hydrocortisone had an inhibitory effect (half-maximal inhibition at 2.76 x 10(-7) M). This model could be a useful in vitro indicator for the in vivo pharmacological actions of anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789072      PMCID: PMC1379905          DOI: 10.1111/j.1365-2125.1989.tb05416.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy.

Authors:  A Engström-Laurent; R Hällgren
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

2.  Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies.

Authors:  L B Dahl; I M Dahl; A Engström-Laurent; K Granath
Journal:  Ann Rheum Dis       Date:  1985-12       Impact factor: 19.103

3.  Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis.

Authors:  E Seppälä; M Nissilä; H Isomäki; P Nuotio; E Nykänen; O Laitinen; H Vapaatalo
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980

4.  The effect of diflunisal on hyaluronic acid production by 'activated' human synovial fibroblasts.

Authors:  M Yaron; I Yaron
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

Review 5.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

6.  Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures.

Authors:  I Yaron; F A Meyer; J M Dayer; I Bleiberg; M Yaron
Journal:  Arthritis Rheum       Date:  1989-02
  6 in total
  3 in total

1.  Diclofenac induced apoptosis via altering PI3K/Akt/MAPK signaling axis in HCT 116 more efficiently compared to SW480 colon cancer cells.

Authors:  Elif Damla Arisan; Zehragül Ergül; Gülnihal Bozdağ; Özge Rencüzoğulları; Ajda Çoker-Gürkan; Pınar Obakan-Yerlikaya; Deniz Coşkun; Narçin Palavan-Ünsal
Journal:  Mol Biol Rep       Date:  2018-11-08       Impact factor: 2.316

2.  Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cells.

Authors:  J D Cleary; S W Chapman; R L Nolan
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

3.  Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.

Authors:  P Bertin; F Lapicque; E Payan; M Rigaud; F Bailleul; S Jaeger; R Treves; P Netter
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.